Bernard LA SCOLA

Prof. Bernard LA SCOLA

<sup>1</sup> Aix-Marseille Univ., Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), UM63 CNRS 7278 IRD 198 INSERM U1095, Facultés de Médecine et de Pharmacie, Marseille, France
+1
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
PGPhilippe Gautret
Philippe Gautret
JLJean-Christophe Lagier
Jean-Christophe Lagier
PPPhilippe Parola
Philippe Parola
VHVan Thuan Hoang
Van Thuan Hoang
LMLine Meddeb
Line Meddeb
Didier RaoultDidier Raoult
Didier Raoult

15 August 2009 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
PSPiseth Seng
Piseth Seng
MDMichel Drancourt
Michel Drancourt
FGFrédérique Gouriet
Frédérique Gouriet
BSBernard LA SCOLA
Bernard LA SCOLA
PFPierre‐Edouard Fournier
Pierre‐Edouard Fournier
Didier RaoultDidier Raoult
Didier Raoult
Background. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry accurately identifies both selected bacteria and

1 December 2012 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
JLJ.-C. Lagier
J.-C. Lagier
FAF. Armougom
F. Armougom
MMM. Million
M. Million
PHP. Hugon
P. Hugon
IPI. Pagnier
I. Pagnier
Didier RaoultDidier Raoult
Didier Raoult
Comprehensive determination of the microbial composition of the gut microbiota and the relationships with health and disease are major challenges in the 21st century. Metagenomic analysis of the human gut microbiota detects mostly uncultured bacteria. We studied stools from two lean Africans and one obese European, using 212 different culture conditions (microbial culturomics), and tested the colonies by using mass spectrometry and 16S rRNA amplification and sequencing. In parallel, we analysed the same three samples by pyrosequencing 16S rRNA amplicons targeting the V6 region. The 32 500 colonies obtained by culturomics have yielded 340 species of bacteria from seven phyla and 117 genera, including two species from rare phyla (Deinococcus-Thermus and Synergistetes, five fungi, and a giant virus (Senegalvirus). The microbiome identified by culturomics included 174 species never described previously in the human gut, including 31 new species and genera for which the genomes were sequenced, generating c. 10 000 new unknown genes (ORFans), which will help in future molecular studies. Among these, the new species Microvirga massiliensis has the largest bacterial genome so far obtained from a human, and Senegalvirus is the largest virus reported in the human gut. Concurrent metagenomic analysis of the same samples produced 698 phylotypes, including 282 known species, 51 of which overlapped with the microbiome identified by culturomics. Thus, culturomics complements metagenomics by overcoming the depth bias inherent in metagenomic approaches.

7 November 2016 in Nature Microbiology
Verified
Journal Article
Open access
JLJean-Christophe Lagier
Jean-Christophe Lagier
SKSaber Khelaifia
Saber Khelaifia
MAMaryam Tidjani Alou
Maryam Tidjani Alou
SNSokhna Ndongo
Sokhna Ndongo
Niokhor DIONENiokhor DIONE
Niokhor DIONE
Didier RaoultDidier Raoult
Didier Raoult
Metagenomics revolutionized the understanding of the relations among the human microbiome, health and diseases, but generated a countless number of sequences that have not been assigned to a known microorganism1. The pure culture of prokaryotes, neglected in recent decades, remains essential to elucidating the role of these organisms2. We recently introduced microbial culturomics, a culturing approach that uses multiple culture conditions and matrix-assisted laser desorption/ionization–time of flight and 16S rRNA for identification2. Here, we have selected the best culture conditions to increase the number of studied samples and have applied new protocols (fresh-sample inoculation; detection of microcolonies and specific cultures of Proteobacteria and microaerophilic and halophilic prokaryotes) to address the weaknesses of the previous studies3–5. We identified 1,057 prokaryotic species, thereby adding 531 species to the human gut repertoire: 146 bacteria known in humans but not in the gut, 187 bacteria and 1 archaea not previously isolated in humans, and 197 potentially new species. Genome sequencing was performed on the new species. By comparing the results of the metagenomic and culturomic analyses, we show that the use of culturomics allows the culture of organisms corresponding to sequences previously not assigned. Altogether, culturomics doubles the number of species isolated at least once from the human gut.

28 March 2003 in Science
Verified
Journal Article
Closed access
PDF file
BSBernard LA SCOLA
Bernard LA SCOLA
SAStéphane Audic
Stéphane Audic
CRCatherine Robert
Catherine Robert
LJLiang Jungang
Liang Jungang
XLXavier de Lamballerie
Xavier de Lamballerie
DRDidier Raoult
Didier Raoult

1 January 2015 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
JLJean-Christophe Lagier
Jean-Christophe Lagier
PHPerrine Hugon
Perrine Hugon
SKSaber Khelaifia
Saber Khelaifia
PFPierre-Edouard Fournier
Pierre-Edouard Fournier
BSBernard LA SCOLA
Bernard LA SCOLA
Didier RaoultDidier Raoult
Didier Raoult
SUMMARY: Bacterial culture was the first method used to describe the human microbiota, but this method is considered outdated by many researchers. Metagenomics studies have since been applied to clinical microbiology; however, a “dark matter” of prokaryotes, which corresponds to a hole in our knowledge and includes minority bacterial populations, is not elucidated by these studies. By replicating the natural environment, environmental microbiologists were the first to reduce the “great plate count anomaly,” which corresponds to the difference between microscopic and culture counts. The revolution in bacterial identification also allowed rapid progress. 16S rRNA bacterial identification allowed the accurate identification of new species. Mass spectrometry allowed the high-throughput identification of rare species and the detection of new species. By using these methods and by increasing the number of culture conditions, culturomics allowed the extension of the known human gut repertoire to levels equivalent to those of pyrosequencing. Finally, taxonogenomics strategies became an emerging method for describing new species, associating the genome sequence of the bacteria systematically. We provide a comprehensive review on these topics, demonstrating that both empirical and hypothesis-driven approaches will enable a rapid increase in the identification of the human prokaryote repertoire.